DNA damage induces phosphorylation of the amino terminus of p53.
暂无分享,去创建一个
Y Taya | K. Sakaguchi | E. Appella | J. Siliciano | M. Kastan | C. Canman | Y. Taya | M B Kastan | J D Siliciano | K Sakaguchi | E Appella | C E Canman
[1] T. Jacks,et al. Mutations in the p53 and SCID genes cooperate in tumorigenesis. , 1996, Genes & development.
[2] T. Graeber,et al. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status , 1994, Molecular and cellular biology.
[3] A. Levine,et al. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.
[4] D. Baltimore,et al. Dual roles of ATM in the cellular response to radiation and in cell growth control. , 1996, Genes & development.
[5] G. Chu,et al. DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage. , 1997, Cancer research.
[6] R. Tjian,et al. p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. , 1995, Science.
[7] C. Sunkel,et al. The casein kinase 1 alpha gene of Drosophila melanogaster is developmentally regulated and the kinase activity of the protein induced by DNA damage. , 1996, Journal of cell science.
[8] M. Fiscella,et al. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression. , 1993, Oncogene.
[9] D. Grunwald,et al. Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[10] D. Meek,et al. Phosphorylation of p53 at the casein kinase II site selectively regulates p53-dependent transcriptional repression but not transactivation. , 1996, Nucleic acids research.
[11] Yoichi Taya,et al. DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.
[12] D. Meek,et al. Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases. , 1994, The Journal of biological chemistry.
[13] W. Maltzman,et al. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells , 1984, Molecular and cellular biology.
[14] M. Oren,et al. Sequence‐specific DNA binding by p53: identification of target sites and lack of binding to p53 ‐ MDM2 complexes. , 1993, The EMBO journal.
[15] A. Levine,et al. Mapping of the p53 and mdm-2 interaction domains. , 1993, Molecular and cellular biology.
[16] M. Kastan,et al. Growth factor modulation of p53-mediated growth arrest versus apoptosis. , 1995, Genes & development.
[17] V. Zakian. ATM-related genes: What do they tell us about functions of the human gene? , 1995, Cell.
[18] C. Prives,et al. Functional interaction between p53, the TATA-binding protein (TBP), andTBP-associated factors in vivo , 1996, Molecular and cellular biology.
[19] P. Tegtmeyer,et al. Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation. , 1995, Cancer research.
[20] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[21] D. King,et al. A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. , 1990, International journal of peptide and protein research.
[22] D. Lane,et al. Regulation of the specific DNA binding function of p53 , 1992, Cell.
[23] I. Takenaka,et al. Regulation of the Sequence-specific DNA Binding Function of p53 by Protein Kinase C and Protein Phosphatases (*) , 1995, The Journal of Biological Chemistry.
[24] P. Friedman,et al. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[25] C. Prives,et al. p53: puzzle and paradigm. , 1996, Genes & development.
[26] J. Danska,et al. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. , 1996, Genes & development.
[27] L. Donehower,et al. p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. , 1996, Genes & development.
[28] D. Meek,et al. p53 Is Phosphorylated in Vitro and in Vivo by an Ultraviolet Radiation-induced Protein Kinase Characteristic of the c-Jun Kinase, JNK1 (*) , 1995, The Journal of Biological Chemistry.
[29] T. Hunter,et al. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. , 1991, Methods in enzymology.
[30] P. Howley,et al. In vivo ubiquitination and proteasome-mediated degradation of p53(1). , 1996, Cancer research.
[31] C. Prives,et al. Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases , 1995, Nature.
[32] M. Kastan,et al. p53 and ATM: cell cycle, cell death, and cancer. , 1997, Advances in cancer research.
[33] A. Fornace,et al. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. , 1994, Cancer research.
[34] D. Meek,et al. Phosphorylation of the p53 tumour-suppressor protein at three N-terminal sites by a novel casein kinase I-like enzyme. , 1992, Oncogene.
[35] M. Kitagawa,et al. The consensus motif for phosphorylation by cyclin D1‐Cdk4 is different from that for phosphorylation by cyclin A/E‐Cdk2. , 1996, The EMBO journal.
[36] B. Vogelstein,et al. Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.
[37] M. Lovett,et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.
[38] G. Wahl,et al. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. , 1996, Genes & development.
[39] S. Kusumoto,et al. An Efficient Procedure for Solid-Phase Synthesis of Phosphopeptides by the Fmoc Strategy , 1994 .
[40] M. Karin,et al. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain , 1994, Cell.
[41] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[42] K. Sakaguchi,et al. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53 , 1992, Molecular and cellular biology.
[43] B. Vogelstein,et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.
[44] M. Oren,et al. p53 in growth control and neoplasia. , 1996, Biochimica et biophysica acta.
[45] D. Lane,et al. Immunochemical analysis of the interaction of p53 with MDM2;--fine mapping of the MDM2 binding site on p53 using synthetic peptides. , 1994, Oncogene.
[46] Michael Karin,et al. Ultraviolet Light and Osmotic Stress: Activation of the JNK Cascade Through Multiple Growth Factor and Cytokine Receptors , 1996, Science.
[47] K. Khanna,et al. Defect in Radiation Signal Transduction in Ataxia-telangiectasia. , 1994, International journal of radiation biology.
[48] L. Hartwell,et al. Cell cycle control and cancer. , 1994, Science.
[49] J. Danska,et al. Biochemical and genetic defects in the DNA-dependent protein kinase in murine scid lymphocytes , 1996, Molecular and cellular biology.
[50] M. Pincus,et al. Conformation-dependent phosphorylation of p53. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[51] G. Wahl,et al. p53-dependent cell cycle arrests are preserved in DNA-activated protein kinase-deficient mouse fibroblasts. , 1996, Cancer research.
[52] K. Khanna,et al. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. , 1993, Oncogene.
[53] A. Levine,et al. The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro , 1997, Molecular and cellular biology.
[54] M. Oren,et al. Mdm2 promotes the rapid degradation of p53 , 1997, Nature.